Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 14, 2007 - Issue 2
12
Views
6
CrossRef citations to date
0
Altmetric
Regular Articles

Blood Outgrowth Endothelial Cells as a Vehicle for Transgene Expression of Hepatocyte-Secreted Proteins via Sleeping Beauty

, , , &
Pages 97-104 | Received 20 Nov 2006, Accepted 25 Feb 2007, Published online: 13 Jul 2009

REFERENCES

  • Alobaid N., Alnaeb M. E., Sales K. M., Seifalian A. M., Mikhailidis D. P., Hamilton G. Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease. Endothelium 2005; 12: 243–250
  • Bandyopadhyay P., Kren B. T., Ma X., Steer C. J. Enhanced gene transfer into HuH-7 cells and primary rat hepatocytes using targeted liposomes and polyethylenimine. BioTechniques 1998; 25: 282–292
  • Chen Z. Y., Yant S. R., He C. Y., Meuse L., Shen S., Kay M. A. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Molecular Therapy 2001; 3: 403–410
  • Chuah M. K., Collen D., Vandendriessche T. Preclinical and clinical gene therapy for haemophilia. Haemophilia 2004; 10: 119–125, Suppl 4
  • Cui Z., Geurts A. M., Liu G., Kaufman C. D., Hackett P. B. Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon. Journal of Molecular Biology 2002; 318: 1221–1235
  • Evans J. P., Brinkhous K. M., Brayer G. D., Reisner H. M., High K. A. Canine hemophilia B resulting from a point mutation with unusual consequences. Proceedings of the National Academy of Sciences of the United States of America 1989a; 86: 10095–10099
  • Evans J. P., Watzke H. H., Ware J. L., Stafford D. W., High K. A. Molecular cloning of a cDNA encoding canine factor IX. Blood 1989b; 74: 207–212
  • Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M. P., Wulffraat N., Leboulch P., Lim A., Osborne C. S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J. I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L. E., Wissler M., Prinz C., Rabbitts T. H., Le Deist F., Fischer A., Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–419
  • Hacker C. V., Vink C. A., Wardell T. W., Lee S., Treasure P., Kingsman S. M., Mitrophanous K. A., Miskin J. E. The integration profile of EIAV-based vectors. Molecular Therapy 2006; 14: 536–545
  • Harvey S. B., Stone M. D., Martinez M. B., Nelsestuen G. L. Mutagenesis of the γ-carboxyglutamic acid domain of human factor VII to generate maximum enhancement of the membrane contact site. Journal of Biological Chemistry 2003; 278: 8363–8369
  • Hodges B. L., Taylor K. M., Joseph M. F., Bourgeois S. A., Scheule R. K. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Molecular Therapy 2004; 10: 269–278
  • Hollestelle M. J., Thinnes T., Crain K., Stiko A., Kruijt J. K., van Berkel T. J., Loskutoff D. J., van Mourik J. A. Tissue distribution of factor VIII gene expression in vivo—A closer look. Thrombosis and Haemostasis 2001; 86: 855–861
  • Hwa C., Sebastian A., Aird W. C. Endothelial biomedicine: Its status as an interdisciplinary field, its progress as a basic science, and its translational bench-to-bedside gap. Endothelium 2005; 12: 139–151
  • Ivics Z., Hackett P. B., Plasterk R. H., Izsvák Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997; 91: 501–510
  • Ivics Z., Izsvák Z. Transposons for gene therapy!. Current Gene Therapy 2006; 6: 593–607
  • Kay M. A., Graham F., Leland F., Woo S. L. Therapeutic serum concentrations of human α-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 1995; 21: 815–819
  • Kren B. T., Gosh S. S., Linehan C. L., Roy-Chowdhury N., Hackett P. B., Roy-Chowdhury J., Steer C. J. Hepatocyte-targeted delivery of Sleeping Beauty mediates efficient transposition in vivo. Gene Therapy and Molecular Biology 2003; 7: 231–240
  • Lechardeur D., Lukacs G. L. Intracellular barriers to non-viral gene transfer. Current Gene Therapy 2002; 2: 183–194
  • Lin L., Schmidt B., Teckman J., Perlmutter D. H. A naturally occurring nonpolymerogenic mutant of α1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum. Journal of Biological Chemistry 2001; 276: 33893–33898
  • Lin Y., Chang L., Solovey A., Healey J. F., Lollar P., Hebbel R. P. Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 2002; 99: 457–462
  • Lin Y., Weisdorf D. J., Solovey A., Hebbel R. P. Origins of circulating endothelial cells and endothelial outgrowth from blood. Journal of Clinical Investigation 2000; 105: 71–77
  • Liu F., Song Y., Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266
  • Lozier J. N., Thompson A. R., Hu P. C., Read M., Brinkhous K. M., High K. A., Curiel D. T. Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes. Human Gene Therapy 1994; 5: 313–322
  • Mantovani J., Holic N., Martinez K., Danos O., Perea J. A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Research 2006; 34: e134
  • Miao C. H., Thompson A. R., Loeb K., Ye X. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Molecular Therapy 2001; 3: 947–957
  • Nakai H., Montini E., Fuess S., Storm T. A., Grompe M., Kay M. A. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nature Genetics 2003; 34: 297–302
  • Nishikawa M., Huang L. Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Human Gene Therapy 2001; 12: 861–870
  • Notley C., Killoran A., Cameron C., Wynd K., Hough C., Lillicrap D. The canine factor VIII 3′-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivo. Human Gene Therapy 2002; 13: 1583–1593
  • Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. “Green mice” as a source of ubiquitous green cells. FEBS Letters 1997; 407: 313–319
  • Park C. W., Park J., Kren B. T., Steer C. J. Sleeping Beauty transposition in the mouse genome is associated with changes in DNA methylation at the site of insertion. Genomics 2006; 88: 204–213
  • Pelisek J., Fuchs A., Engelmann M. G., Shimizu M., Golda A., Mekkaoui C., Rolland P. H., Nikol S. Vascular endothelial growth factor response in porcine coronary and peripheral arteries using nonsurgical occlusion model, local delivery, and liposome-mediated gene transfer. Endothelium 2003; 10: 247–255
  • Perlmutter D. H. Alpha1-antitrypsin deficiency: Liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum. Methods in Molecular Biology 2003; 232: 39–56
  • Pipe S. W. Coagulation factors with improved properties for hemophilia gene therapy. Seminars in Thrombosis and Hemostasis 2004; 30: 227–237
  • Rui E., Grimm D., Huang Z., Kay M. A. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. Human Gene Therapy 2005; 16: 558–570
  • Tenenbaum L., Lehtonen E., Monahan P. E. Evaluation of risks related to the use of adeno-associated virus-based vectors. Current Gene Therapy 2003; 3: 545–565
  • Tio R. A., Wijpkema J. S., Tan E. S., Asselbergs F. W., Hospers G. A., Jessurun G. A., Zijlstra F. Functional characteristics of coronary vasomotor function following intramyocardial gene therapy with naked DNA encoding for vascular endothelial growth factor165. Endothelium 2005; 12: 103–106
  • Walsh C. Gene therapy for hemophilia: Are viral vectors really feasible?. Journal of Thrombosis and Haemostasis 2003a; 1: 218–219
  • Walsh C. E. Gene therapy progress and prospects: Gene therapy for the hemophilias. Gene Therapy 2003b; 10: 999–1003
  • Wei J., Jarmy G., Genuneit J., Debatin K.-M., Beltinger C. Human blood late outgrowth endothelial cells for gene therapy of cancer: Determinants of efficacy. Gene Therapy 2007; 14: 344–356
  • Yant S. R., Meuse L., Chiu W., Ivics Z., Izsvák Z., Kay M. A. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nature Genetics 2000; 25: 35–41
  • Yant S. R., Wu X., Huang Y., Garrison B., Burgess S. M., Kay M. A. High-resolution genome-wide mapping of transposon integration in mammals. Molecular and Cellular Biology 2005; 25: 2085–2094
  • Young J. L., Benoit J. N., Dean D. A. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Therapy 2003; 10: 1465–1470
  • Zhan H. C., Liu D. P., Liang C. C. Insulator: From chromatin domain boundary to gene regulation. Human Genetics 2001; 109: 471–478

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.